<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <activities>
            <item>
              <date>2017-05-11T21:00:31Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <chamber>Senate</chamber>
          <subcommittees />
        </item>
      </billCommittees>
    </committees>
    <congress>115</congress>
    <originChamber>Senate</originChamber>
    <version>1.0.0</version>
    <summaries>
      <billSummaries>
        <item>
          <actionDate>2017-05-11</actionDate>
          <updateDate>2017-05-11T04:00:00Z</updateDate>
          <text><![CDATA[<p><strong>Making Pharmaceutical Markets More Competitive Act</strong></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to&nbsp;prioritize the review of generic drug applications and supplements&nbsp;with respect to&nbsp;drugs that are in a shortage or for which there are not more than three approved drugs.</p> <p>The holder of an approved drug application must notify the FDA within 180 days of withdrawing or transferring the application or withdrawing the drug from sale.</p> <p>The FDA must maintain a list of generic drugs with three or fewer holders of approved applications. </p>]]></text>
          <name>Introduced in Senate</name>
          <lastSummaryUpdateDate>2018-02-02T15:12:52Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in Senate</actionDesc>
          <versionCode>00</versionCode>
        </item>
      </billSummaries>
    </summaries>
    <billNumber>1115</billNumber>
    <relatedBills>
      <item>
        <congress>115</congress>
        <type>S</type>
        <latestAction>
          <actionDate>2017-05-11</actionDate>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 76.</text>
        </latestAction>
        <latestTitle>FDA Reauthorization Act of 2017</latestTitle>
        <number>934</number>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <congress>115</congress>
        <type>HR</type>
        <latestAction>
          <actionDate>2017-05-26</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <latestTitle>Making Pharmaceutical Markets More Competitive Act</latestTitle>
        <number>2562</number>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <laws />
    <billType>S</billType>
    <calendarNumbers />
    <recordedVotes />
    <textVersions>
      <item>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115s1115is/xml/BILLS-115s1115is.xml</url>
          </item>
        </formats>
        <type>Introduced in Senate</type>
        <date>2017-05-11T04:00:00Z</date>
      </item>
    </textVersions>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <cosponsors>
      <item>
        <sponsorshipWithdrawnDate />
        <state>MO</state>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <lastName>McCaskill</lastName>
        <sponsorshipDate>2017-05-11</sponsorshipDate>
        <party>D</party>
        <firstName>Claire</firstName>
        <identifiers>
          <bioguideId>M001170</bioguideId>
          <lisID>1820</lisID>
          <gpoId>8252</gpoId>
        </identifiers>
        <middleName />
        <bioguideId>M001170</bioguideId>
        <fullName>Sen. McCaskill, Claire [D-MO]</fullName>
      </item>
      <item>
        <sponsorshipWithdrawnDate />
        <state>AR</state>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <lastName>Cotton</lastName>
        <sponsorshipDate>2017-05-11</sponsorshipDate>
        <party>R</party>
        <firstName>Tom</firstName>
        <identifiers>
          <bioguideId>C001095</bioguideId>
          <lisID>2098</lisID>
          <gpoId />
        </identifiers>
        <middleName />
        <bioguideId>C001095</bioguideId>
        <fullName>Sen. Cotton, Tom [R-AR]</fullName>
      </item>
      <item>
        <sponsorshipWithdrawnDate />
        <state>MN</state>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <lastName>Franken</lastName>
        <sponsorshipDate>2017-05-11</sponsorshipDate>
        <party>D</party>
        <firstName>Al</firstName>
        <identifiers>
          <bioguideId>F000457</bioguideId>
          <lisID>1969</lisID>
          <gpoId>8339</gpoId>
        </identifiers>
        <middleName />
        <bioguideId>F000457</bioguideId>
        <fullName>Sen. Franken, Al [D-MN]</fullName>
      </item>
    </cosponsors>
    <createDate>2017-05-12T00:26:39Z</createDate>
    <title>Making Pharmaceutical Markets More Competitive Act</title>
    <amendments />
    <actions>
      <item>
        <actionDate>2017-05-11</actionDate>
        <committee>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionCode>10000</actionCode>
        <type>IntroReferral</type>
        <committee />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <links />
        <text>Introduced in Senate</text>
        <actionDate>2017-05-11</actionDate>
      </item>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
      <actionTypeCounts>
        <introducedInSenate>1</introducedInSenate>
        <referredToCommittee>1</referredToCommittee>
      </actionTypeCounts>
    </actions>
    <introducedDate>2017-05-11</introducedDate>
    <committeeReports />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Administrative remedies</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <sponsors>
      <item>
        <state>ME</state>
        <fullName>Sen. Collins, Susan M. [R-ME]</fullName>
        <party>R</party>
        <lastName>COLLINS</lastName>
        <firstName>SUSAN</firstName>
        <identifiers>
          <bioguideId>C001035</bioguideId>
          <gpoId>8291</gpoId>
          <lisID>1541</lisID>
        </identifiers>
        <middleName>MARGARET</middleName>
        <byRequestType />
        <bioguideId>C001035</bioguideId>
      </item>
    </sponsors>
    <titles>
      <item>
        <chamberCode />
        <title>A bill to improve access to prescription drugs.</title>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>Making Pharmaceutical Markets More Competitive Act</title>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>Making Pharmaceutical Markets More Competitive Act</title>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <chamberName />
      </item>
      <item>
        <chamberCode />
        <title>Making Pharmaceutical Markets More Competitive Act</title>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <parentTitleType />
        <chamberName />
      </item>
    </titles>
    <updateDate>2019-04-18T16:36:06Z</updateDate>
    <notes />
    <latestAction>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <actionDate>2017-05-11</actionDate>
      <links />
    </latestAction>
    <cboCostEstimates />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

